Mylan announced the launch of Mesna injection 100mg/mL, the generic version of Baxter‘s Mesnex injection.

Mesnex injection is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide-induced hemorrhagic cystitis. Mesnex reacts chemically with the urotoxic ifosfamide metabolites (acrolein and 4-hydroxy-ifosfamide) in the kidney resulting in detoxification.

Mesna injection is available from Mylan in 1,000mg/10mL multiple-dose vials in 10-vial packs.

For more information call (800) RX-MYLAN or visit